TickerFacts.

Company research / MLAB

Mesa Laboratories Inc (MLAB)

Build a valuation ↗↓ Download CSV

SEC name MESA LABORATORIES INC /CO/ · CIK 0000724004 · Nasdaq · Industrial Instruments For Measurement, Display, and Control

  • Sector Manufacturing
  • Incorporated CO
  • Fiscal year ends Mar 31

For the year ended 2026-03-31, Mesa Laboratories Inc reported revenue of $249.13M. Revenue grew 3.4% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $249.72M.

Key ratios (year ended 2026-03-31)

63.5%
Gross margin
7.4%
Operating margin
2.7%
Net margin
3.6%
Return on year-end equity
3.4%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 8-K (current report) · 2026-10-13

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period endedTTM to
2026-06-30		2026-03-312025-03-312024-03-312023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-31
Revenue$249.72M$249.13M$240.98M$216.19M$219.08M$184.34M$133.94M$117.69M$103.14M$96.18M$93.67M
Cost of Revenue$89.38M$90.86M$90.11M$82.94M$85.39M$75.25M$46.92M$52.33M$42.22M$41.56M$40.43M
Gross Profit$160.34M$158.27M$150.87M$133.25M$133.69M$109.09M$87.01M$65.36M$60.92M$54.62M$53.24M
R&D Expense$20.05M$20.31M$19.52M$19.30M$20.49M$15.77M$10.39M$6.36M$3.51M$3.54M$4.16M
Operating Income$22.48M$18.51M$16.34M-$272.07M$3.32M$4.70M$12.36M$7.92M$9.78M$2.18M$16.31M
Depreciation & Amortizationn/an/an/an/a$33.82M$25.07M$17.66M$12.99M$9.43M$9.47M$8.74M
EBITDAn/an/an/an/a$37.14M$29.77M$30.02M$20.91M$19.21M$11.65M$25.05M
Net Income$4.80M$6.71M-$1.97M-$254.25M$930.0K$1.87M$3.27Mn/an/an/an/a
EPS (Diluted)n/a$1.21-$0.36-$47.20$0.17$0.35$0.64$0.41$1.86-$0.79$2.91
Total Assets$419.22M$427.75M$433.35M$446.80M$661.83M$707.37M$601.48M$409.11M$156.77M$164.10M$171.73M
Total Liabilities$230.46M$241.50M$273.52M$301.40M$268.35M$313.57M$195.25M$189.09M$45.46M$64.74M$73.91M
Long-Term Debt$66.09M$67.50M$71.25Mn/an/an/an/an/a$23.00M$46.62B$55.25M
Shareholders' Equity$188.76M$186.25M$159.83M$145.39M$393.48M$393.80M$406.23M$220.01M$111.31M$99.36M$97.82M
Cash & Equivalents$30.70M$26.93M$27.32M$28.21M$32.91M$49.35M$263.87M$81.38M$10.19M$5.47M$5.82M
Operating Cash Flow$55.67M$42.83M$46.81M$44.13M$27.98M$39.22M$37.07M$26.99M$30.55M$25.72M$17.30M
Capital Expenditures$2.80M$3.25M$4.25M$2.57M$4.54M$4.43M$1.99M$1.50M$1.26M$2.80Mn/a
Free Cash Flow$52.87M$39.58M$42.56M$41.57M$23.44M$34.79M$35.08M$25.49M$29.29M$22.92Mn/a
Dividends Paid$3.53M$3.52M$3.47M$3.45M$3.41M$3.34M$3.17M$2.72M$2.46M$2.41M$2.35M
Shares Outstanding5.60M5.52M5.46M5.39M5.37M5.27M5.14M4.39M3.89M3.80M3.73M
Dividends Per Sharen/a$0.64$0.64$0.64$0.64$0.64$0.64$0.64$0.64n/an/a
Weighted Average Diluted Sharesn/a5.57M5.42M5.39M5.36M5.33M5.12M4.37M4.03M3.77M3.84M
EPS (Basic)n/a$1.22-$0.36-$47.20$0.17$0.36$0.66$0.42$1.95-$0.79$3.04

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView